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Abstract 
 
5-Hydroxytryptamine 1A receptor and galanin receptor 1 belong to the G-protein-coupled receptors 
superfamily and they have been described to heterodimerize triggering an anomalous physiological 
state that would underly depression. Zinc supplementation has been widely reported to improve 
treatment against major depressive disorder. Our work has focused on the study and characterization of 
these receptors and its relationships with zinc both under purified conditions and in cell culture. To this 
aim, we have designed a strategy to purify the receptors in a conformationally active state.  We have 
used receptors tagged with the monoclonal Rho-1D4 antibody, and employed ligand assisted 
purification in order to successfully purify both receptors in a properly folded and active state. The 
interaction between both purified receptors has been analyzed by surface plasmon resonance in order to 
determine the kinetics of dimerization. Zinc effect on heteromer has also been tested using the same 
methodology, but exposing the 5-hydroxytryptamine 1A receptor to zinc before the binding 
experiment. These results, combined with FRET measurements, in the absence and presence of zinc, 
suggest that this ion is capable of disrupting this interaction. Moreover, molecular modelling suggests 
that there is a coincidence between zinc binding sites and heterodimerization interfaces for the 
serotonin receptor. 
Our results establish a rational explanation for the role of zinc in the molecular processes associated 
with receptor-receptor interactions and its relationship with depression, in agreement with previously 
reported evidence for the positive effects of zinc in depression treatment, and the involvement of our 
target dimer in the same disease.  
 
 
 
 
 
 
 
 
Keywords: G-protein-coupled receptor, heterodimerization, protein stability, purified receptor, galanin 
receptor, serotonin receptor, G-protein signaling, zinc, depression  
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Introduction 
 
5-Hydroxytryptamine receptor 1A (5-HT1A) belongs to class A of G-protein coupled receptors 
(GPCRs) superfamily [1] and plays an important role in mediating mood effects in the brain where it is 
found at high concentrations in the hippocampus, lateral septum, cortical areas and the mesencephalic 
raphe nuclei [2]. Functionally, 5-HT1A underlies the molecular mechanism of major depressive and 
anxiolytic disorders [3]. Its signaling mechanism involves binding and activating the heterotrimeric G-
protein Gi/G0. 5-HT1A has been reported to homo and heterodimerize with other GPCRs [4,5], although 
the details and the physiological role of these interactions have not yet been fully elucidated. 5-HT1A 
heterodimerization with the galanin 1 receptor (GalR1) has been recently reported [6]. GalR1 belongs to 
the same family of GPCRs that 5-HT1A, and interacts with the same G-protein subtype but in this case 
it is widespread throughout the human body, particularly in brain, spinal cord, small intestine and 
pancreas [7]. GalR1 is becoming increasingly the focus of interest because of its potential role in a 
number of different pathological states with high prevalence in our society, like nicotine dependence 
[8,9] status epilepticus [10] and cancer [11]. In addition, it has also been involved in major depressive 
disorder by modulating 5-HT1A functionality via specific heterodimerization with this serotonin 
receptor [6]. This interaction would antagonize 5-HT1A neurotransmission, and GalR1 antagonists could 
act as effective antidepressant drugs [12]. Although this interaction has only been demonstrated 
recently, it was first suggested more than two decades ago [13]. On the other side, zinc has also been 
proposed to be associated with depressive disorder [14] and this could be mediated by its interaction 
with the 5-HT1A receptor. Clinical studies have shown that zinc supplementation increases the 
efficiency of the 5-HT1A receptor ligands citalopram and imipramine used in depression treatment 
[15,16]. Moreover, zinc has been associated with other GPCRs, for example being the agonist for the 
GPR39 receptor [17], another GPCR also linked with depressive disorder [18]. Based on the 
established link between zinc and 5-HT1A, and of this receptor with GalR1, we hypothesized that zinc 
could be involved in altering the heterodimerization process between 5-HT1A and GalR1.  
In order to test this hypothesis we have undertaken a detailed characterization of the heterodimerization 
process of these two receptors by means of spectroscopic methods. We set up to perform this 
characterization by means of surface plasmon resonance (SPR) spectroscopy. To this aim we have 
purified the receptors by Rho-1D4 immunopurification in the presence of ligand, and analyzed in detail 
its molecular properties by UV-visible and fluorescence spectroscopy and immunofluorescence 
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detection. We have determined that the purified receptors are in a correctly folded functional state. 
Furthermore, we have been able to follow the specific kinetic features of the dimerization process of 
the purified receptors in real time for the first time by using SPR, and more importantly we have found 
that zinc impairs the heterodimerization process of these receptors. These results have also been 
confirmed in vivo by Förster resonance energy transfer (FRET) spectroscopy measurements of cells 
expressing the two receptors. Taken together these results suggest that the heterodimerization process 
is regulated by zinc.  
 
Materials and methods 
 
Receptor expression and characterization 
Plasmid constructs. Rho-1D4 tag is a specific sequence of the bovine visual GPCR rhodopsin that 
corresponds to the epitope for the monoclonal Rho-1D4 antibody. This tag was added, at the C-
terminus, by inverse PCR to the expression vectors pCDNA3.1 contaning either GalR1 or 5-HT1A genes 
(Missouri S&T cDNA Resource Center, US), using the following primers: Fw: 5’ 
ACGGAGACGAGCCAGGTGGCCCCGGCCTGACTCGAGTCTAGAGGGCC 3’ and Rv: 5’ 
GGCCGGGGCCACCTGGCTCGTCTCCGTCACATGAGTACAATTGGTTG3’- for GalR1 gene and 
Fw: 5’ ACGGAGACGAGCCAGGTGGCCCCGGCCTGACTCGATAGAGGGCCCG 3’ and Rv: 
5’GGCCGGGGCCACCTGGCTCGTCTCCGTCTGGCGGCAGAACTTACACT for 5-HT1A gene. 
Resulting constructs were sequenced to check both appropriate tag addition and unspecific mutation 
absence (Stabvida, Portugal). p5-HT1A-ECFP and pGalR1-EYFP constructs were kindly provided by 
Dr. Borroto-Escuela (Karolinska Institute, Sweden) and pECFP-EYFP was obtained by subcloning 
PCR amplified EYFP onto the pECFP empty vector.   
Protein expression and purification. The constructs were transiently transfected into HEK-293S GnTi- 
cells (EACC, UK) using polyethylenimine (Polysciences, Germany) as previously described [19]. This 
cell line was used because it lacks glycosylation and allows a better visualization of the protein bands 
in electrophoretic gels. Cells were routinely grown in DMEM-F12 media (Labclinics, Spain) 
supplemented with 10% FBS, penicillin-streptomycin (100u/ml) and 2mM L-glutamine (Sigma, Spain) 
at 37ºC and 5% CO2 atmosphere. For protein purification cells were harvested 48h after transfection 
and pelleted at 4000g during 20min. The pellet was then solubilized in 10 ml per harvested plate in tris 
buffered saline (TBS) containing 2% Triton X-100, 100μM phenylmethylsulfonyl fluoride and 1M of 
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receptor agonist, galanin 1-29 (Sigma, Spain) for GalR1 receptor and 8-OH-DPAT (Tocris, UK) for 5-
HT1A, at 4ºC during 1h. Solubilized cells were centrifuged at 35000rpm for 35min at 4ºC and the 
supernatant was incubated by gently nutating with CNBr-activated Sepharose 4B Fast Flow (GE 
healthcare, Spain) coupled to Rho-1D4 antibody (Cell Essentials, US) during 2.5h. The sepharose 
beads were recovered and washed with 50mM MES buffer, pH 6.0 (Sigma, Spain) containing 0.05% 
dodecyl maltoside (DM) (Anatrace, UK) for five times. Elution was performed during 3h with 50mM 
MES buffer pH 6.0 containing 0.05% DM and 0.5mM Rho-1D4 9-mer peptide (TETSQVAPA) (Unitat 
de Tècniques Separatives i Síntesi de Pèptids, Universitat de Barcelona, Spain).  
Purified protein quantification. Protein spectra were recorded using Cary100 UV-vis spectrophotomer 
(Cary, Australia) between 250nm and 350nm. Then, purified protein concentration was calculated 
using receptors extinction molar coefficient, obtained from ProtParam with accession numbers P08908 
for 5-HT1A and P47211 for GalR1 respectively. 
Blue-native PAGE. 2g of each purified receptor were mixed with native loading buffer (5% glycerol, 
0.04% ponceau red in water) and were loaded into tricine (Sigma, Spain) blue native PAGE gel (3-
14%), as described previously [20]. The gel was run for 4h at 100V and room temperature (RT), using 
two different proteins standards; bovine serum albumin (BSA) (Sigma, Spain) and the protein ladder 
NativeMark™ Unstained Protein Standard (Life technologies, US).  
Western Blot. 500ng of each receptor were mixed with denaturing loading buffer and loaded onto an 
SDS-PAGE gel (3-14%).  The gel was run for 40min at 250V in Laemmli running buffer and using 
SDS7B2 pre-stained marker (Sigma, Spain) as a protein standard. The proteins were subsequently 
transferred onto a nitrocellulose membrane (Sigma, Spain), blocked with blocking buffer (5% skimmed 
milk in tris buffered saline buffer (TBS)) and incubated with Rho-1D4 (dilution 1:10000 from stock) as 
primary antibody and anti-mouse IgG conjugated to horseradish peroxidase as secondary antibody 
(Santa Cruz Biotechnology, USA) in TBS. The blots were developed using substrate SuperSignal West 
Pico Chemiluminiscent Substrate (Luminol/H2O2) (ThermoFisher Scientific, France). 
Immunofluorescence Microscopy. Cells were seeded in glass coverslips for 24 h and transfected with 
pCDNA3.1+-GalR1-1D4 and pCDNA3.1+-5-HT1A-1D4 using polyethylenimine as described above. 
One day after transfection, cells were washed with phosphate buffered saline (PBS) (Sigma, Spain) and 
fixed with formalin (Sigma, Spain) for 20 min. After washing twice with PBS, cells were blocked with 
blocking buffer during 1 h at RT. Then cells were incubated with the Rho-1D4 antibody (dilution 
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1/2000 from stock) for 30min at RT, washed with TTBS (TBS containing 0.1% tween-20 (Sigma, 
Spain)) and incubated with anti-mouse FITC (dilution 1/200 from stock) (Sigma, Spain) during 1h 
more. Coverslips were mounted using Vectashield Mounting medium with DAPI (Vector Labs, UK). 
Cell images were taken by inverted fluorescence microscopy using Nikon Eclipse Ti microscope 
(Isaza, Spain). 
Protein stability assay. Purified proteins at a concentration of 1M or L-Trp (12M) were exposed to 
dithiothreitol (DTT) (Sigma, Spain) using different concentrations (0, 1.5, 3, 4.5, 6 and 10mM) for 
15min and the proteins were subsequently exposed to 6M of guanidine hydrochloride (GndHCl) 
(Fisher Scientific, France) for 30 min at RT. Protein intrinsic fluorescence spectra was measured at RT 
on a QuantaMaster 4 spectrofluorimeter (PTI, USA), using 295nm as excitation wavelength (to 
minimize the contribution of tyrosine fluorescence) and 310nm-400nm as emission wavelength range. 
Spectra where corrected for background fluorescence from buffer, DTT and GndHCl. Data were 
smoothed using PeakFit (Systat Software, USA) and normalized using the same software.  
G-protein activation assay.  For activation experiments, purified Gα subunits, Gi1 and Gi2, were 
purchased from Prospec (Ness Ziona, Israel). Purified 5-HT1A and GalR1 activities were tested by 
measuring Gi2 and Gi1 activation, respectively. Since receptors were purified bound to their 
agonist, activation measurements were performed using PTI spectrofluorimeter by monitoring G-
protein intrinsic fluorescence before and after addition of GTPS. The spectrofluorimeter settings were 
280nm as excitation wavelength and 338nm as emission wavelength. Experimental conditions were: 
5nM receptor, 100nM Gα subunit, 25mM Tris pH 7.5, 100mM NaCl, 5mM MgCl2, 2.5mM DTT, 
0.06% DM.  30M GTPS was added to the sample after waiting for spectral stabilization. 
Heterodimerization assays in cells and in purified system  
FRET assays. HEK293T cells were transiently co-transfected as explained above in six well plates 
with the p5-HT1A-ECFP and pGalR1-EYFP vectors at a 1:1 ratio and pCFP-EYFP in DMEM media 
(Sigma, Spain) supplemented with 10% FBS, penicillin-streptomycin (100u/ml), 2mM L-glutamine 
and different zinc chloride (ZnCl2) concentrations (0, 50, 100 and 200M). pECFP-EYFP transfected 
wells were used as negative controls. Two days after transfection cells were harvested and resuspended 
in PBS containing 0.1g·l-1 CaCl2, 0.1g·l-1 MgCl2 and 0.1g·l-1 D-glucose (Sigma, Spain). Then cells were 
seeded onto 96-well black plates. Cell concentration was adjusted by means of protein quantification 
kit (Fluka, Spain). Finally, FRET spectra were measured using an Infinite M200 plate reader (Tecan, 
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Switezerland). Excitation wavelength was set at 410nm and emission was recorded from 455 to 560 
nm. Data was smoothed and normalized by using PeakFit. 
Protein-protein interaction analysis by SPR spectroscopy 
Sensorchip preparation. SPR experiments were performed using Biacore 2000 (GE healthcare, 
Germany). Two flow cells of the CMD 50 d SPR sensorchip (Xantec Bioanalytics, Germany) were 
activated as previously described [21]. Each flow cell was then coated with Rho-1D4 as the primary 
antibody for the working surface and IgG1 (Sigma, Germany) for a negative control surface, both at a 
concentration of 0.1mg/ml in 10mM sodium acetate buffer pH 5. Then the surfaces were inactivated 
using 1M ethanolamine (Sigma, Germany). Immobilization of the Rho-1D4 antibody yielded 250 
resonance units (RU) corresponding to 1.7 fmol/mm2 (surface saturation was calculated by the amount 
of antibody bound, knowing that 1000 RU are equivalent to 1ng/mm2). GalR1, in 50mM MES 
containing 1mM CaCl2 at pH 6 (running buffer) was then injected and bound to the Rho-1D4 antibody 
coated surface until saturation was reached. Flow rate was set to 5 µl/min.  
Heterodimerization assay. For 5-HT1A injections, the same buffer as for GalR1 injection was used. 
Increasing concentrations of 5-HT1A (50, 100 and 200nM) were injected to the GalR1 coated surface. 
Two rounds of surface regeneration with 0.5% SDS were performed, before coating again with GalR1. 
These cycles of regeneration and repeated immobilization of GalR1 were done between each 5-HT1A 
injection. Control injections were performed on an IgG1-coated surface and control data was subtracted 
from the GalR1/5-HT1A binding curves. SPR results were further analyzed for kinetic parameters. 
Binding constants were calculated by nonlinear curve fitting of the sensorgrams using BIAevaluation 
software (GE Healthcare, Germany).  
Zinc exposed heterodimerization assays. In this case, 5-HT1A that was going to be injected had been 
previously incubated with 200M ZnCl2. Then, the injection was performed over GalR1 saturated 
surface in the running buffer. The surface was regenerated between each experiment. Bulk refractive 
index changes, originated from changes in the running solution due to the presence of zinc, were 
subtracted in order to facilitate recognition of protein binding and dissociation steps. 
Construction of an atomistic model of the 5-HT1A receptor by homology modeling 
A starting model of the human 5-HT1A receptor was constructed by homology modeling using the 5-
HT1B receptor as a template (PDB ID 4IAR). The sequences of the two receptors were aligned, taking 
into account the conserved motifs found in all GPCRs, as well as the location of the disulfide bridges. 
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These motifs, together with salt bridges, are important factors in constraining the conformation of the 
extracellular and transmembrane domains of the 5-HT1A receptor. From the aligned sequences, a 
starting model of the receptor was constructed using the Modeller 9 version 8 (9v8) software [22]. 
Model validation was carried out using the MOE program (Chemical Computing Group Inc, Canada). 
In a subsequent step, the selective antagonist Rec 15/3079 was docked into the starting model using the 
GLIDE software [23]. Finally, the ligand-receptor complex was embedded in a lipid bilayer and refined 
using molecular dynamics.  Specifically, the protein was embedded in a box consisting in a 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) lipids and water molecules generated and 
equilibrated according to a previously described procedure [24]. The box had an initial size of 10.3 x 
8.0 x 10.2nm3 (XYZ), organized in such a way that the bilayer plane was oriented on the XY plane. 
Before protein insertion, the box contained 256 lipids (corresponding to an area per lipid of 0.64 nm2) 
and circa 17000 water molecules. The protein was placed in the center of the box, and the overlapping 
molecules were removed. Particularly, all water molecules with oxygen atoms closer than 0.40nm to a 
non-hydrogen atom of the protein, as well as all lipid molecules with at least one atom closer than 
0.25nm to a non-hydrogen atom of the protein, were removed. This resulted in a final system 
containing 197 lipids and circa 16000 water molecules. Next, 114 randomly selected water molecules 
were replaced by 58 sodium and 56 chloride ions, providing a neutral system with a concentration of 
approximately 0.2M NaCl. This concentration is fairly similar to that found in biological organisms, 
although they exhibit different intra and extracellular ion concentrations. 
Sampling was carried out for 500ns using GROMACS package 4.6 [25]. From the simulations an 
average structure was generated and used for the identification of putative zinc binding sites. 
Accordingly, a zinc probe with the features of the zinc ion was passed through the model surface using 
the GRID22 (Molecular Discovery Ltd., UK) probe as implemented MOE program. 
 
Results 
 
Receptor expression and purification. Rho-1D4 tag was selected for purification due to three main 
reasons: small size, recognition by a very specific antibody and standardized purification method for 
rhodopsin, which belongs to the same GPCR family. Accordingly, 5-HT1A and GalR1 encoding genes 
were tagged with this Rho-1D4 immunogenic epitope for their purification. Moreover, the receptors 
were expressed in HEK293S GnTi- cells (lacking N-acetyl-glucosaminyltransferase activity) in order to 
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facilitate their electrophoretic analysis. Immunocytochemical staining of the tagged receptors clearly 
showed that the receptors were properly expressed and localized to the cell membrane (Fig. 1).  
The rhodopsin standard immunopurification protocol was adapted and optimized for our receptors: 
triton X-100 was used instead of DM as solubilization detergent and MES was used as elution buffer 
(see Materials and Methods). The purified receptors were analyzed by Western blot and blue-native 
PAGE (Fig. 2). Western blot analysis revealed two bands for GalR1 corresponding to pure monomeric 
(≈39 KDa) and dimeric forms (≈78 KDa), whereas 5-HT1A showed only one band, corresponding to the 
monomer (≈46 KDa) (Fig. 2a). Under native conditions, in the blue-native PAGE gel, we obtained only 
monomeric bands for both proteins (Fig. 2b). Altogether, the electrophoretic results indicate that, under 
our purification conditions, the receptors are in a monomeric state for both receptors but in the case of 
GalR1 a dimeric form could also be detected possibly due to the effect of the denaturing SDS agent.  
Purified receptors folding state characterization by means of steady state fluorescence spectroscopy. 
The presence of monomeric forms of the receptor under native conditions already suggested that the 
receptors were presumably in a native state but further proof was needed of correct folding of the 
receptors. To this aim we analyzed the Trp intrinsic steady state fluorescence of the purified receptors. 
Two parameters were carefully analyzed, the maximum emission wavelength and the fluorescence 
intensity. It is known that, under denaturing conditions, the protein maximum intensity band is red 
shifted and intensity decreases. These changes are caused by the fact that after protein unfolding Trp is 
located in a more hydrophilic environment, decreasing its quantum yield and in consequence the 
fluorescent intensity [26]. We used DTT and GdnHCl to detect receptor unfolding which should only 
be possible if the receptor is in a correctly folded state. GalR1 has seven Trp (2% of total amino acid 
composition), and 5-HT1A has the same number of Trp but in this case the proportion over total amino 
acid composition is lower (1.7%). In spite of this slight difference in Trp percentage, the two receptors 
behaved similarly under the two treatments used (Fig. 3). The starting maximum emission wavelength 
observed was slightly different for each receptor, 331nm for GalR1 and 332nm 5-HT1A, because Trp 
residues are in different environments. In the two cases DTT treatment induced a 2nm red shift for both 
receptors, whereas no effect could be observed for L-Trp used as a control (Fig. S1, Supplementary 
material). However, in the case of GalR1 the maximum shift was detected at lower DTT concentration, 
4mM for GalR1 and 6mM for 5-HT1A, as depicted in Fig. 3 (insets), where the maximum wavelength 
change regarding DTT concentration is represented. This would mean that 5-HT1A is more stable under 
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our purification conditions, in agreement with the differences observed in the Western blot. Moreover, 
the two receptors eventually become completely denatured by GdnHCl and spectra typical for free Trp 
were obtained (Fig. S1, Supplementary material). The red shift and intensity decrease observed indicate 
that the two receptors are properly folded and this allows their use for the protein-protein interaction 
analysis carried out in this work.  
G-Protein Activation. We have previously shown that the receptors could be purified in a folded state 
but it is important to know whether or not they are functional. The functionality of the receptors was 
measured by their ability to activate their specific G-proteins by means of a fluorescence spectroscopic 
assay. We used Gi1 for GalR1 and Gi2 for 5-HT1A activation, as it has been previously described 
that our target receptors are able to signal via these specific Gα subunits [27,28], when they are 
activated by their corresponding ligands. Here, adding 8-OH-DPAT for 5-HT1A or galanin (1-29) 
peptide for GalR1 was not necessary because the receptors have been already purified bound to their 
ligands during the purification process. In this study we monitored intrinsic fluorescence changes of a 
highly conserved Trp in G proteins, which fluorescence increases as a result of the conformational 
change induced in the subunit by the receptor upon binding and activation. We could detect activity of 
the receptors in both cases as indicated by the typical saturation fluorescence curve obtained after 
GTPS addition (Fig. 4) [29].  
Zinc effect on 5-HT1A- GalR1 heterodimerization. Once we showed that the receptors can be purified 
in a functionally active state, we carried out a detailed characterization of the heterodimerization 
process between them, and the effect of zinc on the process. We used SPR spectroscopy as the 
analytical technique to follow the interaction between the two receptors receptors due to its capacity of 
studying the molecular recognition event very specifically in a real time manner. In a first step, we 
checked if we were able to detect heterodimerization by SPR. As the receptors were tagged with the 
Rho-1D4 immunogenic epitope, the corresponding Rho-1D4 antibody was immobilized onto the chip 
surface. Then GalR1 was injected until surface saturation was achieved by reaching 1.1-2.2fmol GalR1 
per mm2, and finally 5-HT1A was injected into the running buffer at different concentrations (50, 100 
and 200nM). When the binding experiment was concluded, 0.5% SDS was applied to regenerate the 
surface between each 5-HT1A injection. Since regeneration could also remove GalR1 from the surface, 
the surface was saturated again with this receptor before a new sample of 5-HT1A was injected. Our 
results showed a clear interaction between the receptors and the SPR response amplitude increased as a 
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function of the injected concentration of 5-HT1A (Fig. 5). A global fit analysis of sensorgrams revealed 
nearly identical values for the association rate constants averaging at 1.09×104M-1s-1 (Fig. 5a). 
However, the heterodimer protein complex remained stably bound, when running buffer was flushed 
over the chip surface as shown in the sensorgrams (Fig. 5a). The dissociation phase was fit separately 
for each curve yielding values between 1×10-5s-1 and 8×10-5s-1, and the resulting KD values were 0.9 
and 7nM.  
The next step was to investigate the effect of zinc on the observed heterodimerization. For this 
experiment, the 5-HT1A sample to be injected was previously treated with 200M ZnCl2. 5-HT1A 
ability to bind GalR1 was completely abolished in the ZnCl2 containing sample, as observed by the 
different binding signals with respect to amplitude and kinetics (Fig. 5b). Although a certain degree of 
binding can be detected, the protein complex dissociated completely, when running buffer was flushed 
over the sensorchip. We attribute the positive SPR signal to unspecific binding of 5-HT1A to the 
sensorchip, since the negative control curve (experimental replicate over a surface coated with IgG1) 
exhibited the same curve characteristics including the fast dissociation phase that went below the zero 
baseline (compare Fig. 5b with Fig. S2, Supplementary material).  
In order to provide further evidence that would confirm our SPR results we used a complementary 
approach. We carried out FRET analysis of the process because this is one of the most established 
technologies to study GPCR heterodimerization, and also because the 5-HT1A-GalR1 heteromer was 
first detected using this method [6]. We used standardized protocols for this purposes that should 
validate the reliability of our results. With this purpose 5-HT1A and GalR1 receptors were tagged with 
ECFP (excitation at 410nm and emission at 480nm) and EYFP (excitation: 517nm and emission 
525nm) respectively and transient transfection was carried out by adding ZnCl2 in the transfection 
media at the indicated concentrations mentioned (see Materials and Methods). The same experiment 
was performed with ECFP-EYFP fusion protein as negative control (Fig. S3, Supplementary material).  
For our receptors, under physiological conditions, the presence of FRET could be clearly observed 
(Fig. 6, continous trace). EYFP band is present when excitation is set at 410nm (ECFP excitation 
wavelength), whereas the ECFP band (compared to the expressed protein alone band) is smaller due to 
the energy transfer from ECFP to EYFP. After zinc exposure, at a concentration of 50M ZnCl2, the 
FRET signal was significantly diminished (there is an increment of ECFP emission and a concomitant 
decrease in EYFP emission) (Fig. 6, dashed trace). The results clearly show that zinc affects the 
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fluorescent energy transfer between the two fluorescent proteins tagged to the receptors. Higher zinc 
concentrations caused only minor changes. The FRET and SPR results taken together confirm our 
initial hypothesis that zinc antagonizes heteromer formation between GalR1 and 5-HT1A.  
Identification of putative binding sites of Zn on the 5-HT1A receptor  
Based on previous results [30], it appeared that zinc could directly interact with the 5-HT1A receptor. 
Our FRET and SPR results suggest such an interaction and that the interaction sites could match with 
heterodimerization sites. So, molecular modeling was applied in order to get further insights into this 
question. The results of this calculation are shown pictorially in Fig. 7 where the spheres represent 
favorable sites for zinc binding. Most of the putative binding sites are located on the extracellular and 
intracellular loops, although a few of them are located on the transmembrane regions including TM1, 
and the TM4 -TM5 and TM6-TM7 interfaces.  
 
 
Discussion 
 
Homo- and heterodimerization have emerged as a very important mechanism for regulating GPCRs 
function and signaling [31]. Unbalancing these receptor-receptor interactions can have physiological 
consequences and play a role in the physiopathogenesis of a number of diseases. In the case of the 
receptors we have studied, it was recently reported that the 5-HT1A and GalR1 receptors could 
heterodimerize and that this interaction could be relevant in the molecular mechanism of depression 
[6]. . We decided to get a deeper insight into this interaction by studying in detail the process in a 
purified system. Furthermore, we hypothesized that zinc could affect this interaction and we have 
analyzed the effect of this ion on the heterodimerization process. We based our hypothesis on the fact 
that zinc plays an important role in many biological processes [32], especially in those involved in 
mental disorders as we are going to discuss further. 
We have purified the two receptors by using a strategy that has been proven useful for other GPCRs 
[33]. This approach consisted in adding the Rho-1D4 tag (the epitope corresponding to the last 9 amino 
acids of rhodopsin) at the C-terminal tail of the receptor and using triton X-100 as solubilizing agent. In 
addition we have used HEK293S GnTi- cell line for expression of the recombinant receptors. This cell 
line abolishes protein glycosylation facilitating analysis by electrophoretic methods. This strategy has 
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allowed efficient expression and purification of the receptors -for characterization purposes- without 
changing, in principle, the native protein expression and cellular localization. Our preliminary 
purification efforts resulted in aggregated receptors that did not show functional activity (data not 
shown), we solved this problem by purifying the receptors in the presence of their ligand, that had been 
successfully used in the purification of other receptors [34,35]. In this case we were able to obtain 
purified receptors that did not appear to be aggregated judged from the UV spectra and electrophoretic 
pattern. The blue native gel indicated that both receptors were purified in a monomeric state.  In turn, 
our Western blot (from SDS-PAGE gel) analysis showed what appeared to be a dimeric band in the 
case of the GalR1 that was not apparent in the blue native gel. This may seem contradictory but we 
should take into account that SDS can induce artifactual oligomerization [36]. The electrophoretic 
pattern, however, did not assure that the protein was correctly folded. This was verified by means of 
both Trp intrinsic fluorescence measurements and immunocytochemical localization. Trp intrinsic 
fluorescence had already been used for this purpose [37]. We found that after DTT treatment, the 
fluorescence maximum emission band underwent a shift reflecting a change in the Trp environment 
compatible with a partial loss of protein structure (Fig. 3). Moreover, after GdnHCl exposure, our 
receptor spectra shape changed to that of free L-Trp one, indicating that the protein had been 
completely denatured. A difference was detected in the denaturing pattern derived from these 
experiments for 5-HT1A and GalR1. This was the shift observed at higher DTT concentrations for 
5HT1A receptor and this could be interpreted as this receptor being more resistant to partial unfolding 
than GalR1. Immunocytochemical analysis showed that the two receptors were expressed at the cell 
membrane (and not retained in the endoplasmic reticulum) (Fig.1) reinforcing that the purified 
receptors were correctly folded under our experimental conditions. A final proof of the native status of 
the purified receptors was obtained from determining its G-protein activation capacity. In both cases 
we were able to detect G-protein activation by means of a fluorescence assay after GTPS addition 
(Fig. 4) proving that the receptors had been purified in a functional state although the slightly different 
activation patterns observed could reflect subtle differences in activation kinetics. This, together with 
the Trp fluorescence results suggest, that the purified receptors have slightly different functional 
conformations in the purified state, caused either by the intrinsic characteristics of each receptor or by 
the purification conditions. Nevertheless, this does not represent any problem in our subsequent 
interaction analysis.  
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The purification of the two receptors was successfully completed and this allowed us to investigate the 
heterodimerization process in real time by means of SPR spectroscopy that has been shown to be 
appropriate for studying protein-protein interactions [38]. We have been able to successfully 
characterize the rhodopsin activation process by means of this technique [21]. In spite of the many 
advantages of this technique like high sensitivity and reliability, its application to GPCR analysis is still 
under development [39]. Furthermore, no previous study involving our receptors has been reported and 
this highlights the novelty of our approach. Our SPR measurements clearly showed that 5HT1A and 
GalR1 heterodimerize in the purified state and that this interaction is stable under our experimental 
conditions (Fig. 5). We derived an association rate constant  (Ka) of 1.09×104M-1×s-1 and by taking the 
highest and lowest dissociation rate constants (Kd, see above in Results section), we end up with 
dissociation constants KD between 0.9 and 7nM indicating a tight and stable complex formation. Rate 
and affinity constants for this dimerization process are of similar magnitude as the rhodopsin-
transducin interaction investigated by the same methodological SPR approach [40].  
One of the important goals of our study was to test the effect of zinc on the heterodimerization process 
between our receptors. Zinc is a widespread metal ion involved in many physiological processes and 
found in all body tissues including the eye, brain and others. Zinc deficiency can result in unhealthy 
state and be the cause of certain pathological states like depression [41,42]. We have previously shown 
a clear effect of zinc on the structure and stability of visual rhodopsin [43] and other examples 
involving zinc and GPCRs could be found [44,45]. Zinc has also been shown to interact with other 
GPCRs, including its cognate receptor GPR39 [46] and 5-HT1A where it has been proposed to act as an 
allosteric modulator of the serotonin receptor function [30]. We find that zinc impairs 5-HT1A-GalR1 
heterodimerization. When we exposed 5-HT1A receptor to ZnCl2 and injected it over GalR1, 
immobilized on the SPR sensorchip, we could detect relative low levels of receptor binding, compared 
with control sample in the absence of zinc (Fig. 5a and 5b), that could be removed upon washing with 
buffer. This lower level of binding and the complete removal of the receptor after washing would 
indicate a transient interaction much less stable than the one observed in the absence of zinc. The 
described data suggests that the presence of zinc impairs heterodimerization of the two receptors. We 
also analyzed the effect of zinc by means of FRET on cells expressing the receptors in order to further 
validate the results obtained in the purified system. We observed, in HEK293T cells, a clear decrease 
in FRET intensity in the presence of zinc consistent with heterodimer formation impairment (Fig. 6). 
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The FRET measurements in cells are in agreement with the SPR measurements obtained with purified 
receptors. According to the SPR analysis, zinc impaired heterodimer formation completely but under in 
vivo conditions, in the FRET measurements, we cannot discard that some heterodimerization was still 
present at 50M ZnCl2, due to the presence of the ECFP second emission band that could mask EYFP 
less intense signals, but we can clearly see a significant decrease in the FRET signal at 50M ZnCl2. A 
meta-analysis study performed in 1643 depressed patients and 804 controls revealed that the average 
zinc blood concentration was 13.31M and 15.18M respectively [47]. Other studies describe that the 
zinc concentration increases significantly in the synaptic environment and, based on experimental 
results, they suggest 50M as a physiological relevant zinc concentration [30]. Therefore, the zinc 
concentration used in our FRET experiments are in agreement with the reported physiological 
concentration for zinc. The difference between the FRET and SPR data could result from additional 
zinc binding components that are present in living cells, but not in the controlled environment of the 
SPR experiments. However, higher concentrations of ZnCl2 did not significantly alter the FRET signal 
suggesting the existence of mechanisms that may counterbalance the zinc concentration increment 
effect in the cell environment. Alternatively, it is possible that in cells, 50M ZnCl2, completely 
abolished heterodimer formation and this would indicate that the SPR results reveal the intrinsic 
features of the receptors because in this case we are analyzing them in their purified state.   
Concerning the mechanism by which zinc ions prevent heterodimer formation, one possible 
explanation is that zinc acts as a protein-protein interaction inhibitor by binding to a site located on the 
interface surface impairing dimerization. In spite of the fact that the interacting interface of the 5-HT1A-
GalR1 heterodimer has yet to be identified, our present modeling results confirm that the putative zinc-
binding sites at TM1, and the TM4-TM5 and TM6-TM7 interfaces (Fig. 7) may be located on the 
putative oligomerization interfaces found in the analysis of the diverse GPCR crystallographic 
structures available: either TM1-TM2-H8 or TM5, sometimes together with TM4 and others with 
TM6, also involving the ICL2 intracellular loop [48,49]. Moreover, previous reports suggest the 
specific involvement of TM4 and TM5 in such an interaction [4]. These results provide support to a 
specific role of zinc as an inhibitor of protein-protein interactions but further studies, like mutagenesis 
of specific amino acids, should be carried out in order to fully describe the specific details of the Zn-5-
HT1A-GalR1 interactions. 
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In conclusion, here we have described an effect of zinc on the GalR1-5-HT1A heterodimer formation. 
Our results fit nicely with the antidepressive effects that had been widely described for zinc, and 
validate our hypothesis that the presence of the metal ion can be important in modulating the balance 
between monomers/heterodimers of the receptors studied and that this may play a significant role in the 
development of major depressive disorder. Our findings suggest that zinc is a modulator of the specific 
heterodimerization between 5-HT1A-GalR1 and that zinc homeostasis can play a critical role in this 
interaction. Thus, in a given environment with appropriate zinc concentration, the receptors would be 
present mostly in their monomeric form, with only a small fraction of heteromers, and that would 
correspond to a healthy state. Upon zinc levels decrease, the heteromer fraction could possibly increase 
giving rise to a disease phenotype (Fig. 8).  
Our results reinforce the notion of 5-HT1A-GalR1 heterodimer as one of the underlying molecular 
causes of the depressive phenotype, and provide a rationale for the zinc clinical effects that have been 
previously reported. Additionally, having the receptors in a purified active state provides new 
opportunities for structural determination by appropriate techniques, such as X-ray crystallography. 
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Figure legends 
 
Fig. 1 Expression and cellular localization of 5-HT1A and GalR1. HEK 293S GnTi- cells, transiently 
transfected with the receptor genes were fixed, immunostained with FITC (see Materials and Methods) 
and analyzed by fluorescence microscopy. 5-HT1A (a-c) and GalR1 (d-f) receptors are shown in green 
and nuclei stained with DAPI, in blue. 
 
Fig. 2 Electrophoretic analysis of the expressed purified recombinant receptors. (a) Western-Blot. 
Samples were loaded onto a SDS-PAGE gel and upon transferring onto a nitrocellulose membrane, 
receptors were immunodetected. Loading order from left to right was as follows: GalR1 and 5-HT1A. 
Bands reveal the presence of our specific proteins but also the presence of species with higher apparent 
molecular weight for GalR1 protein. (b) Blue-native PAGE. Samples in 50mM MES buffer, 5% 
glycerol and 0.04% Ponceau (final concentrations) were loaded according to the following order from 
left to right: molecular weight marker (MW), BSA, GalR1 and 5-HT1A. Double marker was used to 
confirm ladder band weight, because of the variations of native marker migration in different native 
gels. The gel reveals that the receptors are purified as monomers. The position of the molecular weight 
protein marker is indicated on the left in kDa. 
 
Fig. 3 Chemical unfolding of the purified receptors. Effect of DTT and GdnHCl on the maximum 
emission wavelength (max) of purified GalR1 (a) and 5-HT1A receptor (b). The different conditions are 
native protein (    ), 10mM DTT exposure (----) and 10mM DTT and 6M GdnHCl exposure (….). The 
proteins (1μM) were treated with 10mM DTT and 6M GdnHCl during 30min at RT. For GalR1, DTT 
induces a λmax red shift from 331nm to 333nm and GdnHCl together with DTT induces λmax a shift 
to 352nm, giving a similar shape to the free Trp solution spectra. For 5-HT1A, DTT induces λmax red 
shift from 332nm to 334nm and GdnHCl together with DTT induces λmax a shift to 352nm as in 
GalR1. Inset. Dose response of the DTT induced max shift for both receptors.  Purified proteins were 
exposed to DTT using the following concentrations (0, 1.5, 3, 4.5, 6 and 10mM) during 15 min for 
each concentration. max was determined from the difference between the max of DTT treated 
samples and control. Curves correspond to the average of three independent experiments 
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Fig. 4 G-protein activation of the purified receptors. GTPS binding to the G protein upon receptor 
activation was detected by means of a fluorescence assay. Time-based emission scans for Gi1 
activation by GalR1 (a) and Gi2 by 5-HT1A (b) are presented. In both cases we can see a curve 
showing the three typical phases of an activation experiment [29]: baseline, GTPγS binding and 
saturation phase or plateau, concluding that, under our specific purification conditions we obtained 
active proteins. Curves correspond to the average of three independent experiments 
 
Fig. 5 SPR analysis of 5-HT1A-GalR1 dimerization in the presence and absence of zinc. (a) Specific 
heterodimerization between the two purified receptors. Data show a direct relationship between the 
concentration of 5-HT1A injected -onto a GalR1 coated sensorchip- and the amount of receptor bound. 
Response curves for GalR1 binding upon 200nM 5-HT1A injection (Ka = 1.04 x104M-1s-1) (    ), 100nM 
(Ka = 1.07 x104M-1s-1) (----) and 50nM (Ka = 1.17 x104M-1s-1) injection (….). SPR curves show clearly 
the interaction between the two receptors with an average association rate constant (Ka) of 1.09x104M-
1s-1 (Ka was calculated after subtraction of the negative control to each sample). It is interesting to 
highlight that nearly no dissociation can be detected. (b) Effect of ZnCl2 exposure on 5-HT1A- GalR1 
heteromer by SPR. Response curve shows no binding of GalR1 after 5-HT1A-ZnCl2 mixture injection. 
Although there is a small binding response, it dissociates completely 
 
Fig. 6 In vivo heterodimerization analyzed by FRET spectroscopy. Effect of ZnCl2 exposure on 5-
HT1A- GalR1 heteromer by FRET. Fluorescent spectra show a decrease in the FRET signal, suggesting 
heterodimer dissociation, after 50M (----) ZnCl2 exposure compared to non-exposed receptors (    ). At 
higher concentrations, such as 100M (….) and 200M. no further increase can be detected when 
compared to the 50 µM ZnCl2 sample. Arrows show differences in fluorescence intensity upon zinc 
addition. 
 
Fig. 7 Zinc binding sites determined by molecular modeling. Ribbon representation of the constructed 
5HT1A receptor model (blue) resulting from our present studies. Spheres in green represent the binding 
sites of the zinc ion computed using a specific probe 
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Fig. 8 Scheme of zinc inhibition of heterodimer formation. The effect of zinc on 5-HT1A-GalR1 
heterodimer formation is summarized. Under physiological zinc deficient conditions, the heterodimer 
would be the predominant form, causing a disease phenotype. In the presence of high zinc 
concentration, the metal ion can interact with the receptor (in our case we propose with 5-HT1A), 
impairing dimer formation and this would reflect a healthy phenotype 
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